Morgan Stanley Resumes Coverage of Unilever (UL) with an Overweight View

Core Viewpoint - Unilever PLC is focusing on growth in faster-growing segments such as beauty, wellness, and personal care, with a strategic shift supported by significant investment in mergers and acquisitions [2][3]. Group 1: Company Strategy and Financials - Morgan Stanley has resumed coverage of Unilever with an Overweight rating and a price target of $60.10, indicating confidence in the company's growth trajectory [2]. - Unilever plans to invest approximately €1.5 billion ($1.74 billion) annually in mergers and acquisitions, particularly targeting the US market, reflecting its belief in long-term growth opportunities [3]. - Following the demerger of its ice cream business, Unilever expects its second-half operating margin to be at least 19.5%, an improvement from 18.5% prior to the split [4]. Group 2: Market Performance and Shareholder Impact - Unilever retained a 19.9% stake in the newly listed Magnum Ice Cream Company, which debuted with a market value below analyst expectations of around $9.1 billion, affected by index funds exiting after the spinoff [5]. - Shareholders received one Magnum share for every five Unilever shares owned, but the stock's eligibility for major indices like the FTSE was flagged as a risk, impacting early trading performance [5].